Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Engineering T lymphocyte antigen specificity.

R L Bolhuis1, E Sturm, J W Gratama

  • 1Department of Immunology, Dr. Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.

Journal of Cellular Biochemistry
|December 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Statistical analysis of EBSD data confirms pronounced classical and non-classical pervasive crystallographic twinning in rotaliid foraminiferal calcite.

Scientific reports·2025
Same author

The cool brown dwarf Gliese 229 B is a close binary.

Nature·2024
Same author

Indications and successes of intestinal transplantation in children in the 21st century: A retrospective cohort study.

Clinical nutrition ESPEN·2024
Same author

A dynamical measure of the black hole mass in a quasar 11 billion years ago.

Nature·2024
Same author

Test of the Einstein Equivalence Principle near the Galactic Center Supermassive Black Hole.

Physical review letters·2019
Same author

Star formation inside a galactic outflow.

Nature·2017
Same journal

Zinc Finger Proteins as Regulators of Organ Fibrosis.

Journal of cellular biochemistry·2026
Same journal

Intrinsic Disorder Status in Human Proteins Interacting With SARS-CoV-2 Proteins: Insights From Five Years of Translational Research.

Journal of cellular biochemistry·2026
Same journal

The Effect of Protein Tagging on Aggregation and Phase Separation.

Journal of cellular biochemistry·2026
Same journal

TRIM32 Alleviates the Inflammation in Spinal Cord Injury Progression Through Inducing the Ubiquitination Degradation of TLR4.

Journal of cellular biochemistry·2026
Same journal

Bedaquiline Binding at the Leading Site of Mycobacterium tuberculosis ATP Synthase Induces Distinct Structural and Dynamic Changes.

Journal of cellular biochemistry·2026
Same journal

Agrin Ablation in Osteoblasts Compromises Long Bone Structure and Osteoblastic Differentiation of Mesenchymal Stem Cells.

Journal of cellular biochemistry·2026
See all related articles

Bispecific antibodies harness the immune system to fight cancer by linking immune cells to tumor cells, activating a targeted cell-killing response with minimal toxicity. This review explores their use in immunotherapy and adoptive cell transfer.

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • Bispecific antibodies are engineered proteins with dual specificity.
  • They bridge immune cells and target cells, like cancer cells.
  • This interaction activates immune responses against cancer.

Purpose of the Study:

  • To review the application of bispecific antibodies in cancer immunotherapy.
  • To discuss their role in immune cell activation and cytotoxicity.
  • To explore different bispecific antibody formats and lymphocyte populations for adoptive immunotherapy.

Main Methods:

  • Utilizing the dual specificity of bispecific antibodies to bind tumor-associated antigens and lymphocyte activation sites.
  • Leveraging the natural cellular immune defense system.

Related Experiment Videos

  • Reviewing existing literature on bispecific antibody preparations and chimeric immunoglobulin/T cell receptor constructions.

    • Main Results:

    • Bispecific antibodies effectively link immune cells (e.g., lymphocytes) to cancer cells.
    • This crosslinking triggers lymphocyte activation, leading to cancer cell lysis and cytokine production.
    • The approach utilizes the body's own immune system, resulting in lower toxicity.

    Conclusions:

    • Bispecific antibodies represent a powerful tool for cancer immunotherapy.
    • They offer a targeted approach to activate immune responses against tumors.
    • Further exploration of lymphocyte populations and antibody formats can optimize therapeutic strategies.